View the Latest: Pregnancy
Filter
-
-
KFF Health Tracking Poll: Mifepristone and the Midterms
Poll FindingAmid an ongoing FDA re-review of mifepristone, awareness of the safety and prevalence of the abortion pill remains limited. This KFF poll also finds that the voters who say abortion policy is an important issue for 2026 midterm candidates to discuss are disproportionately Democrats.
-
Medicaid Postpartum Coverage Extension Tracker
TrackerThis page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
-
State Health Coverage for Immigrants and Implications for Health Coverage and Care
Issue BriefNoncitizen immigrants, particularly those who are undocumented, face significant barriers to accessing health coverage and care and are significantly more likely than citizens to be uninsured. This brief provides an overview of state health coverage programs for immigrants, including among states that have taken up options in Medicaid and the Children’s Health Insurance Program (CHIP) to expand coverage for lawfully present immigrants and/or established fully state-funded programs to fill gaps in coverage for immigrants.
-
KFF Poll Finds That Most Adults Lack Confidence in Key Health Agencies to Act Independently — The Monitor
FeatureKFF’s latest Health Tracking Poll finds that confidence in the independence of key government health agencies overseeing food and drug safety and public health is low among the public and across partisans. Most of the public also share a distrust of agriculture, food, and pharmaceutical companies to act in the public’s best interest, compared with doctors and health care providers who are much more trusted among the public. The latest edition of the Monitor also…
-
Medicaid and CHIP Income Eligibility Limits for Pregnant Women as a Percent of the Federal Poverty Level
State Health Facts Indicatoreligibility Medicaid CHIP
-
The Latest on Medication Abortion Access: The Court Awaits the FDA Review
Quick InsightsDespite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion. In the meantime, clinicians may continue to mail mifepristone to pregnant patients seeking abortions regardless of where they live.
-
Deaths and Health Care Issues in ICE Detention Centers Under the Second Trump Administration
Issue BriefThis brief provides an overview of deaths in ICE custody and detention centers under the Trump administration based on KFF analysis of ICE detainee death reporting and news releases and reviews recent reports of health care issues in detention centers.
-
Early Prenatal Care Use Falls, Gaps Widen for Women of Color, CDC Data Show
Quick InsightsWhile the exact reasons for the recent declines in early prenatal care use are not known, disparities in maternal and infant health reflect underlying inequities in insurance coverage, access to care, and social and economic factors.
-
KFF Health Tracking Poll: Knowledge and Views of Medication Abortion
Poll FindingThis KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.